Hypoglycemic effect of insulin-loaded hydrogel-nanogel composite on streptozotocin-induced diabetic rats. 2021

Bao-Xin Li, and Juan Lv, and Xin Zhang, and Can Zhang, and Shu-Qin Guo, and Ru-Jiang Ma, and He Wang, and Yun-Liang Zhang
Department of Endocrinology, Baoding NO.1 Central Hospital, Baoding, Hebei, China.

At present, how to increase insulin rapidly, availably and stably is still a conundrum in the treatment of diabetes mellitus. In vitro studies have shown that insulin can be released from hydrogel-nanogel composite according to the changes of glucose level. This study aimed to observe the glucose-lowering effects and evaluate the safety of the insulin-loaded hydrogel-nanogel composite in diabetic rats. We found that significant glycemic regulation could be observed up to 30 hours after subcutaneous injection, and the fasting blood glucose was reduced effectively. The result of an oral glucose tolerance test showed that the level of insulin expressed a stable increase from 0.5 hours to 3.5 hours, which led to a reduction of glucose with steady steps. Also, compared with Ins group, the Gel+Ins group showed slighter skin and pancreas damage, while the oxidative stress and inflammation response were similar to the normal control group. In conclusion, these results demonstrated that the glucose-lowering action of the insulin-loaded hydrogel-nanogel composite was superior to that of the regular insulin, and might thus become an insulin carrier in the future.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D000080385 Nanogels Three-dimensional biocompatible materials formed by cross-linking a hydrophilic polymeric component (e.g., HYDROGELS). They are typically spherical particles in a size range of 20-250 nm when used for drug delivery applications. Nanocomposite Gel,Nanocomposite Gels,Nanocomposite Hydrogel,Nanocomposite Hydrogels,Gel, Nanocomposite,Hydrogel, Nanocomposite
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013311 Streptozocin An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals. Streptozotocin,2-Deoxy-2-((methylnitrosoamino)carbonyl)amino-D-glucose,Streptozotocine,Zanosar
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D020100 Hydrogels Water swollen, rigid, 3-dimensional network of cross-linked, hydrophilic macromolecules, 20-95% water. They are used in paints, printing inks, foodstuffs, pharmaceuticals, and cosmetics. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydrogel,In Situ Hydrogel,In Situ Hydrogels,Patterned Hydrogel,Patterned Hydrogels,Hydrogel, In Situ,Hydrogel, Patterned

Related Publications

Bao-Xin Li, and Juan Lv, and Xin Zhang, and Can Zhang, and Shu-Qin Guo, and Ru-Jiang Ma, and He Wang, and Yun-Liang Zhang
November 2000, The Journal of pharmacology and experimental therapeutics,
Bao-Xin Li, and Juan Lv, and Xin Zhang, and Can Zhang, and Shu-Qin Guo, and Ru-Jiang Ma, and He Wang, and Yun-Liang Zhang
September 2014, Journal of complementary & integrative medicine,
Bao-Xin Li, and Juan Lv, and Xin Zhang, and Can Zhang, and Shu-Qin Guo, and Ru-Jiang Ma, and He Wang, and Yun-Liang Zhang
June 2001, Journal of ethnopharmacology,
Bao-Xin Li, and Juan Lv, and Xin Zhang, and Can Zhang, and Shu-Qin Guo, and Ru-Jiang Ma, and He Wang, and Yun-Liang Zhang
December 2001, Journal of ethnopharmacology,
Bao-Xin Li, and Juan Lv, and Xin Zhang, and Can Zhang, and Shu-Qin Guo, and Ru-Jiang Ma, and He Wang, and Yun-Liang Zhang
January 2017, Drug design, development and therapy,
Bao-Xin Li, and Juan Lv, and Xin Zhang, and Can Zhang, and Shu-Qin Guo, and Ru-Jiang Ma, and He Wang, and Yun-Liang Zhang
November 2012, BMC complementary and alternative medicine,
Bao-Xin Li, and Juan Lv, and Xin Zhang, and Can Zhang, and Shu-Qin Guo, and Ru-Jiang Ma, and He Wang, and Yun-Liang Zhang
January 2004, Experimental diabesity research,
Bao-Xin Li, and Juan Lv, and Xin Zhang, and Can Zhang, and Shu-Qin Guo, and Ru-Jiang Ma, and He Wang, and Yun-Liang Zhang
September 2005, Journal of ethnopharmacology,
Bao-Xin Li, and Juan Lv, and Xin Zhang, and Can Zhang, and Shu-Qin Guo, and Ru-Jiang Ma, and He Wang, and Yun-Liang Zhang
February 2004, Journal of ethnopharmacology,
Bao-Xin Li, and Juan Lv, and Xin Zhang, and Can Zhang, and Shu-Qin Guo, and Ru-Jiang Ma, and He Wang, and Yun-Liang Zhang
January 2000, The Journal of endocrinology,
Copied contents to your clipboard!